schliessen

Filtern

 

Bibliotheken

hCTR1在非小细胞肺癌中的表达及其临床意义 - Expression and clinical significance of hCTR1 in non-small cell lung cancer

目的 探讨非小细胞肺癌(NSCLC)组织中hCTR1的表达与患者临床病理特征的关系以及减轻铂类药副反应的临床方法.方法 采用免疫组织化学法,检测54例手术后接受含顺铂方案一线化疗的NSCLC患者组织中hCTR1的表达情况,其中35例患者于化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,分析hCTR1表达与NSCLC患者临床特征、病理类型、分化程度、临床分期、化疗疗效及化疗副反应的关系.结果 hCTR1的免疫阳性反应主要定位于NSCLC细胞的细胞质;hCTR1表达与含顺铂方案的化疗疗效及淋巴结转移呈正相关(P=0.02,P=0.01),而与年龄(P=0.29)、性别(P=0.32)、... Full description

Journal Title: 西安交通大学学报:医学版 - Journal of Xi‘an Jiaotong University:Medical Sciences 2014, Vol.35(05), pp.651-654
Main Author: 阳甜
Other Authors: 李洋 , 陈天君 , 高雷 , 陈明伟 , YANG Tian,LI Yang,CHEN Tian-jun,GAO Lei,CHEN Ming-wei
Format: Electronic Article Electronic Article
Language:
Subjects:
Quelle: 维普数据 (Chongqing VIP Information Co.)
ID: ISSN: 1671-8259
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cqvip662243263
title: hCTR1在非小细胞肺癌中的表达及其临床意义 - Expression and clinical significance of hCTR1 in non-small cell lung cancer
format: Article
creator:
  • 阳甜
  • 李洋
  • 陈天君
  • 高雷
  • 陈明伟
  • YANG Tian,LI Yang,CHEN Tian-jun,GAO Lei,CHEN Ming-wei
subjects:
  • 非小细胞肺癌
  • 铜离子转运蛋白1(Hctr1)
  • 顺铂
  • 化疗副反应
  • Non-Small Cell Lung Cancer (Nsclc)
  • Human Copper Transporters 1 (Hctr1)
  • Cisplatin
  • Side Effects of Chemotherapy
ispartof: 西安交通大学学报:医学版 - Journal of Xi‘an Jiaotong University:Medical Sciences, 2014, Vol.35(05), pp.651-654
description: 目的 探讨非小细胞肺癌(NSCLC)组织中hCTR1的表达与患者临床病理特征的关系以及减轻铂类药副反应的临床方法.方法 采用免疫组织化学法,检测54例手术后接受含顺铂方案一线化疗的NSCLC患者组织中hCTR1的表达情况,其中35例患者于化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,分析hCTR1表达与NSCLC患者临床特征、病理类型、分化程度、临床分期、化疗疗效及化疗副反应的关系.结果 hCTR1的免疫阳性反应主要定位于NSCLC细胞的细胞质;hCTR1表达与含顺铂方案的化疗疗效及淋巴结转移呈正相关(P=0.02,P=0.01),而与年龄(P=0.29)、性别(P=0.32)、病理类型(P=0.19)、临床分期(P=0.52)、分化程度(P=0.62)及是否吸烟(P=0.89)无关;化疗副反应大小与性别(P=0.87)及年龄(P=0.47)无关,与在化疗前后是否采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施有关(P <0.05).结论 hCTR1的表达可能是NSCLC患者以铂类为基础治疗的化疗疗效及淋巴结转移的重要预测因子.对于有高表达hCTR1的NSCLC患者化疗时,在化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,可以减轻化疗副反应.
language:
source: 维普数据 (Chongqing VIP Information Co.)
identifier: ISSN: 1671-8259
fulltext: no_fulltext
issn:
  • 1671-8259
  • 16718259
url: Link


@attributes
ID598631053
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid662243263
sourceidcqvip
recordidTN_cqvip662243263
sourceformatDC
sourcesystemPC
display
typearticle
titlehCTR1在非小细胞肺癌中的表达及其临床意义 - Expression and clinical significance of hCTR1 in non-small cell lung cancer
creator阳甜 ; 李洋 ; 陈天君 ; 高雷 ; 陈明伟 ; YANG Tian,LI Yang,CHEN Tian-jun,GAO Lei,CHEN Ming-wei
ispartof西安交通大学学报:医学版 - Journal of Xi‘an Jiaotong University:Medical Sciences, 2014, Vol.35(05), pp.651-654
identifierISSN: 1671-8259
subject非小细胞肺癌 ; 铜离子转运蛋白1(Hctr1) ; 顺铂 ; 化疗副反应 ; Non-Small Cell Lung Cancer (Nsclc); Human Copper Transporters 1 (Hctr1); Cisplatin; Side Effects of Chemotherapy
description
0目的 探讨非小细胞肺癌(NSCLC)组织中hCTR1的表达与患者临床病理特征的关系以及减轻铂类药副反应的临床方法.方法 采用免疫组织化学法,检测54例手术后接受含顺铂方案一线化疗的NSCLC患者组织中hCTR1的表达情况,其中35例患者于化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,分析hCTR1表达与NSCLC患者临床特征、病理类型、分化程度、临床分期、化疗疗效及化疗副反应的关系.结果 hCTR1的免疫阳性反应主要定位于NSCLC细胞的细胞质;hCTR1表达与含顺铂方案的化疗疗效及淋巴结转移呈正相关(P=0.02,P=0.01),而与年龄(P=0.29)、性别(P=0.32)、病理类型(P=0.19)、临床分期(P=0.52)、分化程度(P=0.62)及是否吸烟(P=0.89)无关;化疗副反应大小与性别(P=0.87)及年龄(P=0.47)无关,与在化疗前后是否采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施有关(P <0.05).结论 hCTR1的表达可能是NSCLC患者以铂类为基础治疗的化疗疗效及淋巴结转移的重要预测因子.对于有高表达hCTR1的NSCLC患者化疗时,在化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,可以减轻化疗副反应.
1Objective To investigate the expression of human copper transporters 1 (hCTR1) in patients with non-small cell lung cancer (NSCLC) and analyze its correlation with the clinicopathologic features and methods to reduce the clinical side effects of platinum drugs.Methods In the specimens of 54 lung cancer surgical patients treated with first-line cisplatin-based chemotherapy,the expression of hCTR1 protein was determined with immunohistochemistry.Then we analyzed its correlation with NSCLC clinical features,histological type,degree of differentiation,clinical stage,chemotherapy and side effects of chemotherapy.Results The positive immune reaction of hCTR1 was observed mainly in cytoplasmic staining of NSCLC cells.The expression of hCTR1 had positive correlation with the response to cisplatin-based chemotherapy and lymph node metastasis (P =0.02 and 0.01,respectively).There was no significant correlation between hCTR1 expression and the following factors:age (P=0.29),sex (P=0.32),histological type (P=0.19),clinical stage (P=0.52),differentiation (P=0.62) and smoking (P =0.89).The side effects of chemotherapy was not related to age (P =0.47) and sex(P =0.87).However,hCTR1 expression was significantly related to receiving hydration,reduced glutathione,vitamin B2 and curcumin before and after chemotherapy (P<0.05).Conclusior The expression level of hCTR1 is an important factor that predicts the response to platinum-based chemotherapy and lymph node metastasis in NSCLC patients.For NSCLC patients with high hCTR1 expression,receiving hydration,reduced glutathione,vitamin B2 and curcumin before and after chemotherapy may reduce the side effects of chemotherapy.
relation作者单位: 西安交通大学医学院第一附属医院呼吸内科,陕西西安710061
source维普数据 (Chongqing VIP Information Co.)
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Uhttp://image.cqvip.com/vip1000/qk/90540A/90540A.jpg
search
creatorcontrib
0阳甜
1李洋
2陈天君
3高雷
4陈明伟
5YANG Tian,LI Yang,CHEN Tian-jun,GAO Lei,CHEN Ming-wei
6西安交通大学医学院第一附属医院呼吸内科,陕西西安710061
title
0hCTR1在非小细胞肺癌中的表达及其临床意义
1Expression and clinical significance of hCTR1 in non-small cell lung cancer
description
0目的 探讨非小细胞肺癌(NSCLC)组织中hCTR1的表达与患者临床病理特征的关系以及减轻铂类药副反应的临床方法.方法 采用免疫组织化学法,检测54例手术后接受含顺铂方案一线化疗的NSCLC患者组织中hCTR1的表达情况,其中35例患者于化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,分析hCTR1表达与NSCLC患者临床特征、病理类型、分化程度、临床分期、化疗疗效及化疗副反应的关系.结果 hCTR1的免疫阳性反应主要定位于NSCLC细胞的细胞质;hCTR1表达与含顺铂方案的化疗疗效及淋巴结转移呈正相关(P=0.02,P=0.01),而与年龄(P=0.29)、性别(P=0.32)、病理类型(P=0.19)、临床分期(P=0.52)、分化程度(P=0.62)及是否吸烟(P=0.89)无关;化疗副反应大小与性别(P=0.87)及年龄(P=0.47)无关,与在化疗前后是否采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施有关(P <0.05).结论 hCTR1的表达可能是NSCLC患者以铂类为基础治疗的化疗疗效及淋巴结转移的重要预测因子.对于有高表达hCTR1的NSCLC患者化疗时,在化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,可以减轻化疗副反应.
1Objective To investigate the expression of human copper transporters 1 (hCTR1) in patients with non-small cell lung cancer (NSCLC) and analyze its correlation with the clinicopathologic features and methods to reduce the clinical side effects of platinum drugs.Methods In the specimens of 54 lung cancer surgical patients treated with first-line cisplatin-based chemotherapy,the expression of hCTR1 protein was determined with immunohistochemistry.Then we analyzed its correlation with NSCLC clinical features,histological type,degree of differentiation,clinical stage,chemotherapy and side effects of chemotherapy.Results The positive immune reaction of hCTR1 was observed mainly in cytoplasmic staining of NSCLC cells.The expression of hCTR1 had positive correlation with the response to cisplatin-based chemotherapy and lymph node metastasis (P =0.02 and 0.01,respectively).There was no significant correlation between hCTR1 expression and the following factors:age (P=0.29),sex (P=0.32),histological type (P=0.19),clinical stage (P=0.52),differentiation (P=0.62) and smoking (P =0.89).The side effects of chemotherapy was not related to age (P =0.47) and sex(P =0.87).However,hCTR1 expression was significantly related to receiving hydration,reduced glutathione,vitamin B2 and curcumin before and after chemotherapy (P<0.05).Conclusior The expression level of hCTR1 is an important factor that predicts the response to platinum-based chemotherapy and lymph node metastasis in NSCLC patients.For NSCLC patients with high hCTR1 expression,receiving hydration,reduced glutathione,vitamin B2 and curcumin before and after chemotherapy may reduce the side effects of chemotherapy.
subject
0非小细胞肺癌
1铜离子转运蛋白1(Hctr1)
2顺铂
3化疗副反应
4Non-Small Cell Lung Cancer (Nsclc)
5Human Copper Transporters 1 (Hctr1)
6Cisplatin
7Side Effects of Chemotherapy
general
0chinese
1维普数据 (Chongqing VIP Information Co.)
sourceidcqvip
recordidcqvip662243263
issn
01671-8259
116718259
rsrctypearticle
creationdate2014
startdate20140101
enddate20141231
addtitle
0西安交通大学学报:医学版
1Journal of Xi‘an Jiaotong University:Medical Sciences
searchscopecqvip
scopecqvip
lsr01
0西安交通大学医学院第一附属医院呼吸内科,陕西西安710061
1YANG Tian,LI Yang,CHEN Tian-jun,GAO Lei,CHEN Ming-wei(Respiratory Department, the First Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an 710061, China)
citationpf 651 pt 654 vol 35 issue 05
sort
titlehCTR1在非小细胞肺癌中的表达及其临床意义 - Expression and clinical significance of hCTR1 in non-small cell lung cancer
author阳甜 ; 李洋 ; 陈天君 ; 高雷 ; 陈明伟 ; YANG Tian,LI Yang,CHEN Tian-jun,GAO Lei,CHEN Ming-wei
creationdate20140000
lso0120140000
facets
frbrgroupid8238023185875586595
frbrtype6
creationdate2014
topic
0非小细胞肺癌
1铜离子转运蛋白1(Hctr1)
2顺铂
3化疗副反应
4Non-Small Cell Lung Cancer (Nsclc); Human Copper Transporters 1 (Hctr1); Cisplatin; Side Effects of Chemotherapy
collection维普资讯 (Chongqing VIP Information Co.)
prefilterarticles
rsrctypearticles
creatorcontrib
0阳甜
1李洋
2陈天君
3高雷
4陈明伟
5YANG Tian,LI Yang,CHEN Tian-jun,GAO Lei,CHEN Ming-wei
jtitle
0西安交通大学学报:医学版
1Journal of Xi‘an Jiaotong University:Medical Sciences
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0阳甜
1李洋
2陈天君
3高雷
4陈明伟
5YANG Tian,LI Yang,CHEN Tian-jun,GAO Lei,CHEN Ming-wei
atitlehCTR1在非小细胞肺癌中的表达及其临床意义 - Expression and clinical significance of hCTR1 in non-small cell lung cancer
jtitle西安交通大学学报:医学版
date2014
risdate2014
volume35
issue05
part90540A
spage651
epage654
issn1671-8259
coden90540A
formatjournal
genrearticle
ristypeJOUR
abstract
0目的 探讨非小细胞肺癌(NSCLC)组织中hCTR1的表达与患者临床病理特征的关系以及减轻铂类药副反应的临床方法.方法 采用免疫组织化学法,检测54例手术后接受含顺铂方案一线化疗的NSCLC患者组织中hCTR1的表达情况,其中35例患者于化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,分析hCTR1表达与NSCLC患者临床特征、病理类型、分化程度、临床分期、化疗疗效及化疗副反应的关系.结果 hCTR1的免疫阳性反应主要定位于NSCLC细胞的细胞质;hCTR1表达与含顺铂方案的化疗疗效及淋巴结转移呈正相关(P=0.02,P=0.01),而与年龄(P=0.29)、性别(P=0.32)、病理类型(P=0.19)、临床分期(P=0.52)、分化程度(P=0.62)及是否吸烟(P=0.89)无关;化疗副反应大小与性别(P=0.87)及年龄(P=0.47)无关,与在化疗前后是否采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施有关(P <0.05).结论 hCTR1的表达可能是NSCLC患者以铂类为基础治疗的化疗疗效及淋巴结转移的重要预测因子.对于有高表达hCTR1的NSCLC患者化疗时,在化疗前后采取水化、还原型谷胱甘肽、维生素B2及姜黄素等措施,可以减轻化疗副反应.
1Objective To investigate the expression of human copper transporters 1 (hCTR1) in patients with non-small cell lung cancer (NSCLC) and analyze its correlation with the clinicopathologic features and methods to reduce the clinical side effects of platinum drugs.Methods In the specimens of 54 lung cancer surgical patients treated with first-line cisplatin-based chemotherapy,the expression of hCTR1 protein was determined with immunohistochemistry.Then we analyzed its correlation with NSCLC clinical features,histological type,degree of differentiation,clinical stage,chemotherapy and side effects of chemotherapy.Results The positive immune reaction of hCTR1 was observed mainly in cytoplasmic staining of NSCLC cells.The expression of hCTR1 had positive correlation with the response to cisplatin-based chemotherapy and lymph node metastasis (P =0.02 and 0.01,respectively).There was no significant correlation between hCTR1 expression and the following factors:age (P=0.29),sex (P=0.32),histological type (P=0.19),clinical stage (P=0.52),differentiation (P=0.62) and smoking (P =0.89).The side effects of chemotherapy was not related to age (P =0.47) and sex(P =0.87).However,hCTR1 expression was significantly related to receiving hydration,reduced glutathione,vitamin B2 and curcumin before and after chemotherapy (P<0.05).Conclusior The expression level of hCTR1 is an important factor that predicts the response to platinum-based chemotherapy and lymph node metastasis in NSCLC patients.For NSCLC patients with high hCTR1 expression,receiving hydration,reduced glutathione,vitamin B2 and curcumin before and after chemotherapy may reduce the side effects of chemotherapy.
lad0190540A